<DOC>
	<DOC>NCT02602470</DOC>
	<brief_summary>To survey patients with rosacea about their rosacea treatment preferences as well as to assess potential drivers of rosacea treatment satisfaction.</brief_summary>
	<brief_title>Preferences &amp; Treatment Satisfaction Drivers in Rosacea Patients</brief_title>
	<detailed_description />
	<mesh_term>Rosacea</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Male or female patients of at least 18 years of age at index date At least one prescription for a topical rosacea treatments: Azelaic Acid Gel, Azelaic Acid Cream, Metronidazole Gel, Metronidazole Cream, Metronidazole Emulsion, Metronidazole Lotion, Brimonidine Tartrate Gel At least one medical record with a diagnosis code for rosacea (ICD9: 695.3) At least 6 months of data history prior to the index date Had at least one encounter at the Reliant Medical Group within 3 months prior to 01 January 2015</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>